open access

Vol 26, No 6 (2019)
Original articles — Clinical cardiology
Published online: 2018-08-31
Get Citation

Is downstream cardiac testing required in patients with reduced functional capacity and otherwise negative exercise stress test? A single center observational study

Mark Whitman, Surendran Sabapathy, Carly Jenkins, Lewis Adams
DOI: 10.5603/CJ.a2018.0099
·
Pubmed: 30234905
·
Cardiol J 2019;26(6):753-760.

open access

Vol 26, No 6 (2019)
Original articles — Clinical cardiology
Published online: 2018-08-31

Abstract

Background: Exercise stress testing (EST) in patients with poor functional capacity measured by time
on treadmill is typically deemed inconclusive and usually leads to further downstream testing. The aim
of this study was firstly to evaluate the maximum rate pressure product (MRPP) during initial EST to
assessthe need for follow-up testing; and secondly to investigate if MRPP is better than age predicted
maximum heart rate (APMHR) for diagnostic outcome based on follow up cardiovascular (CV) events
in patients with inconclusive EST due to poor functional capacity.
Methods: From a total of 2761 tests performed, 236 tests were considered inconclusive due to poor
functional capacity which were available for analysis. From receiver operating characteristic (ROC)
analysis, a cut-off value for MRPP of 25000 was chosen using CV events as the outcome measure
(sensitivity 97%, specificity 45%). Cases were then categorised into those with an MRPP > 25000 and
< 25000.
Results: Regardless of treadmill time, any patient attaining an MRPP > 25000 had no abnormal
downstream testing or CV events at 2 years follow-up. On ROC analysis MRPP outperformed APMHR
for sensitivity and specificity (area under curve 0.76 vs. 0.59, respectively).
Conclusions: The results suggest that regardless of functional capacity, individuals whose EST is terminated
at maximal fatigue, with no electrocardiogram evidence or symptoms of myocardial ischemia
and yields an MRPP > 25000, do not require further downstream testing. Furthermore, this group
of patients, while not immune to future CV events, have significantly better outcomes than those not
attaining a MRPP > 25000.

Abstract

Background: Exercise stress testing (EST) in patients with poor functional capacity measured by time
on treadmill is typically deemed inconclusive and usually leads to further downstream testing. The aim
of this study was firstly to evaluate the maximum rate pressure product (MRPP) during initial EST to
assessthe need for follow-up testing; and secondly to investigate if MRPP is better than age predicted
maximum heart rate (APMHR) for diagnostic outcome based on follow up cardiovascular (CV) events
in patients with inconclusive EST due to poor functional capacity.
Methods: From a total of 2761 tests performed, 236 tests were considered inconclusive due to poor
functional capacity which were available for analysis. From receiver operating characteristic (ROC)
analysis, a cut-off value for MRPP of 25000 was chosen using CV events as the outcome measure
(sensitivity 97%, specificity 45%). Cases were then categorised into those with an MRPP > 25000 and
< 25000.
Results: Regardless of treadmill time, any patient attaining an MRPP > 25000 had no abnormal
downstream testing or CV events at 2 years follow-up. On ROC analysis MRPP outperformed APMHR
for sensitivity and specificity (area under curve 0.76 vs. 0.59, respectively).
Conclusions: The results suggest that regardless of functional capacity, individuals whose EST is terminated
at maximal fatigue, with no electrocardiogram evidence or symptoms of myocardial ischemia
and yields an MRPP > 25000, do not require further downstream testing. Furthermore, this group
of patients, while not immune to future CV events, have significantly better outcomes than those not
attaining a MRPP > 25000.

Get Citation

Keywords

rate pressure product, exercise stress testing, myocardial ischemia, double product, myocardial index

About this article
Title

Is downstream cardiac testing required in patients with reduced functional capacity and otherwise negative exercise stress test? A single center observational study

Journal

Cardiology Journal

Issue

Vol 26, No 6 (2019)

Pages

753-760

Published online

2018-08-31

DOI

10.5603/CJ.a2018.0099

Pubmed

30234905

Bibliographic record

Cardiol J 2019;26(6):753-760.

Keywords

rate pressure product
exercise stress testing
myocardial ischemia
double product
myocardial index

Authors

Mark Whitman
Surendran Sabapathy
Carly Jenkins
Lewis Adams

References (31)
  1. Hui SC, Jackson AS, Wier LT. Development of normative values for resting and exercise rate pressure product. Med Sci Sports Exerc. 2000; 32(8): 1520–1527.
  2. Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation. 2001; 104(14): 1694–1740.
  3. Pinkstaff S, Peberdy MA, Kontos MC, et al. Quantifying exertion level during exercise stress testing using percentage of age-predicted maximal heart rate, rate pressure product, and perceived exertion. Mayo Clin Proc. 2010; 85(12): 1095–1100.
  4. Sadrzadeh Rafie AH, Sungar GW, Dewey FE, et al. Prognostic value of double product reserve. Eur J Cardiovasc Prev Rehabil. 2008; 15(5): 541–547.
  5. Villella M, Villella A, Barlera S, et al. Prognostic significance of double product and inadequate double product response to maximal symptom-limited exercise stress testing after myocardial infarction in 6296 patients treated with thrombolytic agents. Am Heart J. 1999; 137(3): 443–452.
  6. Sadrzadeh Rafie AH, Dewey FE, Sungar GW, et al. Age and double product (systolic blood pressure x heart rate) reserve-adjusted modification of the Duke Treadmill Score nomogram in men. Am J Cardiol. 2008; 102(10): 1407–1412.
  7. Fornitano LD, Godoy MF. [Increased rate-pressure product as predictor for the absence of significant obstructive coronary artery disease in patients with positive exercise test]. Arq Bras Cardiol. 2006; 86(2): 138–144.
  8. Snader CE, Marwick TH, Pashkow FJ, et al. Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol. 1997; 30(3): 641–648.
  9. Gulati M, Black HR, Shaw LJ, et al. The prognostic value of a nomogram for exercise capacity in women. N Engl J Med. 2005; 353(5): 468–475.
  10. Bruce RA, Blackmon JR, Jones JW, et al. Exercising testing in adult normal subjects and cardiac patients. Pediatrics. 1963; 32(suppl): 742–756.
  11. Morris CK, Myers J, Froelicher VF, et al. Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am Coll Cardiol. 1993; 22(1): 175–182.
  12. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J. 1973; 85(4): 546–562.
  13. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. 2012.
  14. Engineer RS, Lauer MS, Emerman CL. Chest pain after recent stress test: Is there a warranty? Ann Emerg Med. 2004; 44(4): S47.
  15. Romero-Farina G, Candell-Riera J, Aguadé-Bruix S, et al. Warranty periods for normal myocardial perfusion stress SPECT. J Nucl Cardiol. 2015; 22(1): 44–54.
  16. Jain M, Nkonde C, Lin BA, et al. 85% of maximal age-predicted heart rate is not a valid endpoint for exercise treadmill testing. J Nucl Cardiol. 2011; 18(6): 1026–1035.
  17. Ellestad MH, Wan MK. Predictive implications of stress testing. Follow-up of 2700 subjects after maximum treadmill stress testing. Circulation. 1975; 51(2): 363–369.
  18. Lauer MS, Okin PM, Larson MG, et al. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation. 1996; 93(8): 1520–1526.
  19. Elhendy A, Mahoney DW, Khandheria BK, et al. Prognostic significance of impairment of heart rate response to exercise: impact of left ventricular function and myocardial ischemia. J Am Coll Cardiol. 2003; 42(5): 823–830.
  20. Bouzas-Mosquera MC, Bouzas-Mosquera A, Peteiro J. Excessive blood pressure increase with exercise and risk of all-cause mortality and cardiac events. Eur J Clin Invest. 2016; 46(10): 833–839.
  21. Farzaneh-Far R, Na B, Whooley MA, et al. Left-ventricular power-to-mass ratio at peak exercise predicts mortality, heart failure, and cardiovascular events in patients with stable coronary artery disease: data from the Heart and Soul Study. Cardiology. 2009; 114(3): 226–234.
  22. Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002; 346(11): 793–801.
  23. Bourque JM, Holland BH, Watson DD, et al. Achieving an exercise workload of > or = 10 metabolic equivalents predicts a very low risk of inducible ischemia: does myocardial perfusion imaging have a role? J Am Coll Cardiol. 2009; 54(6): 538–545.
  24. Gobel FL, Norstrom LA, Nelson RR, et al. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978; 57(3): 549–556.
  25. Nelson RR, Gobel FL, Jorgensen CR, et al. Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation. 1974; 50(6): 1179–1189.
  26. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006; 113(6): 791–798.
  27. MBS Online Medicare Benefits Schedule [Internet]. Australian Government, Department of Health; 2016. http://www.health.gov.au/internet/mbsonline/publishing.nsf/Content/a-z (cited 2016 July 27).
  28. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol. 1997; 30(1): 260–315.
  29. Lekven J, Mjos OD, Kjekshus JK. Compensatory mechanisms during graded myocardial ischemia. Am J Cardiol. 1973; 31(4): 467–473.
  30. Vigorito C, De Caprio L, Poto S, et al. Protective role of collaterals in patients with coronary artery occlusion. Int J Cardiol. 1983; 3(4): 401–415.
  31. Peteiro J, Bouzas-Mosquera A, Broullón F, et al. Value of an exercise workload ≥10 metabolic equivalents for predicting inducible myocardial ischemia. Circ Cardiovasc Imaging. 2013; 6(6): 899–907.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl